Search clinical trials for: Sistema Prevena ™(TVAC)

Total 1215 results

IRCCS San Raffaele

Completed

Clinical Study on the Prevention of Surgical Wound Complications for Aneurysmal Thoracic-abdominal Aortic Pathology Using the "PREVENA" System (TVAC)

Toraco Abdominal Aneurysm

Italy
3M
KCI Europe Holding B.V.

Terminated

The Use of PrevenaTM on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.

Wound Infection | Surgical Site Occurences After Sternotomy

Germany, Netherlands, Austria
Thomas Jefferson University
Acelity

Recruiting

Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputation Wound Complications (PREVENA-AMP)

Amputation | Seroma | Wound Infection, Surgical | Wound Dehiscence | Lymph Leakage | Amputation; Postoperative, Sequelae

United States, Italy
Andrew Glennie

Unknown

Incisional Negative Pressure Wound Therapy in Patients Undergoing Spine Surgery

Surgical Site Infection
John Street
3M; University of British Columbia Orthopaedics Research Excellence Fund

Unknown

Negative Pressure Wound Therapy vs. Sterile Dressing for Patients Undergoing Thoracolumbar Spine Surgery

Spinal Cord Injury | Spinal Deformity | Metastatic Disease | Spinal Degeneration

Canada
Masonic Cancer Center, University of Minnesota

Completed

Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients

Obesity | Postoperative Complications | Gynecologic Neoplasms

United States
RWTH Aachen University

Completed

Reduction of Groin Wound Infections After Vascular Surgery by Using an Incision Management System (IMS) (IMS)

Infections

Germany
Western University, Canada
Lawson Health Research Institute

Withdrawn

NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT (NPWTinDIEP)

Breast Cancer | Surgical Site Infection | Wound Dehiscence

Canada
Dartmouth-Hitchcock Medical Center
Southern New Hampshire Medical Center

Terminated

Vacuum Assisted Closure for Cesarean Section (VACCS)

Surgical Wound Infection

United States
Mayo Clinic
3M

Completed

Negative Pressure Wound Therapy for Prevention of Poststernotomy Infection

Surgical Wound Infection

United States
Yale University
National Heart, Lung, and Blood Institute (NHLBI); Oregon Health and Science...

Completed

Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia (PreVent2)

Ventilator-acquired Pneumonia

United States
Dr. Jean E. Starr, MD

Unknown

Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites

Obesity | Diabetes | Peripheral Vascular Disease

United States
University of Calgary
3M

Completed

Negative Pressure Dressing After Saphenous Vein Harvest

Coronary Artery Disease | Wound Complication | Complication of Coronary Artery Bypass Graft

Canada
State University of New York at Buffalo
3M

Completed

Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery

Wound Infection

United States
Progenerative Medical, Inc

Not yet recruiting

Regenn® Therapy System Safety Study

Surgical Wound

United States
University of Maryland, Baltimore

Withdrawn

Incisional Negative Pressure Dressing on Clean Closed Groin Incisions

Complication of Surgical Procedure

United States
University of North Carolina, Chapel Hill
Kinetic Concepts, Inc.

Terminated

Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty

Complications; Arthroplasty, Infection or Inflammation | Wound Complication

United States
St. James's Hospital, Ireland

Not yet recruiting

Application of PREVENA in Reducing Surgical Site Complications Following Reversal of Ileostomy or Colostomy (PRIC)

Ileostomy - Stoma | Colostomy Stoma | Stoma Site Infection

Ireland
University of Aarhus
Randers Regional Hospital

Terminated

Randomized Trial Comparing Prevena and ActiV.A.C. System to Convetional Care After Bascom's Cleft Lift Surgery

Pilonidal Disease

Denmark
Johns Hopkins University
ResMed; Ventus Medical, Inc.

Completed

Sleep Apnea Treatment With Expiratory Resistance(Provent™) (SATER)

Sleep Apnea, Obstructive

United States
3M

Recruiting

Continuous Treatment With PREVENA Therapy for 14 Days

Abdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular Surgery

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) (PNEU-PED-EU-2)

Pneumococcal Infections

Denmark, Finland, Italy, Norway, Sweden
Merck Sharp & Dohme LLC

Completed

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

Measles | Rubella | Mumps | Varicella
Northwell Health

Terminated

A Trial to Evaluate Negative Pressure Incision Management System for Groin Wounds in Vascular Surgery Patients

Surgical Procedure, Unspecified

United States
GlaxoSmithKline

Completed

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Neisseria Meningitidis | Haemophilus Influenzae Type b

Spain
VBI Vaccines Inc.

Completed

A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™

Hepatitis B
Chang Gung Memorial Hospital

Recruiting

Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection

Wound Heal | Periprosthetic Joint Infection

Taiwan
3M

Withdrawn

Prevena™ Incision Management System Over Primarily Closed Hip and Knee Incisions in Patients Immediately Post Total Hip and Knee Arthroplasty (Prevena2009-45)

Total Knee Arthroplasty | Total Hip Arthroplasty | Linear or Emi-linear Incisions
3M

Completed

The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions

Surgical Wound Infection | Surgical Site Infection | Post-operative Complications

United States
Abbey Hardy-Fairbanks
Kinetic Concepts, Inc.

Completed

Negative Pressure Wound Therapy After Cesarean Delivery

Wound Infection | Major Puerperal Infection, Postpartum | Wound Complications | Wound Seroma | Caesarean Section Wound Separation

United States
GlaxoSmithKline

Completed

Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib

Infections, Streptococcal

Netherlands
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) (PNEU-PED-EU-1)

Pneumococcal Infections

Australia, Belgium, Czechia, Estonia, Germany, Greece, Poland, Russian Federation, Spain
Royal Free Hospital NHS Foundation Trust
KCI Europe Holding B.V.

Terminated

Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa (HIDRA)

Hidradenitis Suppurativa

United Kingdom
Merck Sharp & Dohme LLC
MCM Vaccines B.V.

Completed

Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

Virus Diseases | Bacterial Infections
The Cleveland Clinic

Completed

Prevena™ Incisional Negative Pressure Wound Therapy in Re-operative Colorectal Surgery

Surgical Site Infection

United States
University of Vermont Medical Center
Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Dartmouth-Hitchcock... and other collaborators

Unknown

Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery

Peripheral Artery Disease | Claudication | Critical Limb Ischemia

United States
Sanofi

Completed

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infection

United States
Azienda Ospedaliera, Ospedale Civile di Legnano
Acelity

Not yet recruiting

CiNPT for Abdominoplasties in Post-bariatric Patients Study (CAPS)

Obesity | Obesity, Morbid | Surgery--Complications | Surgical Wound Infection | Surgical Site Infection | Wound Infection | Scar | Wound Heal | Obesity, Abdominal | Wound | Wound Contamination | Wound Complication | Scarring | Wound Dehiscence | Incision | Wound; Abdomen | Incision Site Rash | Incision Site Bleeding | Incision Site... and other conditions
MCM Vaccines B.V.
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Virus Diseases | Bacterial Infections
Western University, Canada
Kinetic Concepts, Inc.

Unknown

Negative Pressure Wound Therapy for the Prevention of Surgical Site Infection Following Lower Limb Revascularization

Peripheral Vascular Diseases | Surgical Wound Infection

Canada
Denver Health and Hospital Authority
3M

Withdrawn

The Role of VAC Therapy Devices in Promoting Closure of Enterocutaneous Fistulae (ECF)

Fistulae

United States
GlaxoSmithKline
Aeras

Completed

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants

Tuberculosis

Gambia
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) (PNEU-PED)

Pneumococcal Infections | Pneumococcal Vaccines

United States, Puerto Rico, Thailand, Turkey
Memorial Sloan Kettering Cancer Center
3M; Miami Cancer Institute

Completed

Negative Pressure Wound Therapy in Post-Operative Incision Management

Negative-Pressure Wound Therapy

United States
Merck Sharp & Dohme LLC
MCM Vaccines B.V.

Completed

A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Virus Diseases | Bacterial Infections
MCM Vaccines B.V.
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)

Virus Diseases | Bacterial Infections
GlaxoSmithKline

Completed

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

Haemophilus Influenzae Type b

United States
GlaxoSmithKline

Completed

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Neisseria Meningitidis | Haemophilus Influenzae Type b

Germany, France, Canada
Merck Sharp & Dohme LLC

Completed

Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029)

Pneumococcal Infections
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED) (PNEU-WAY PED)

Pneumococcal Infections

South Africa, Thailand, Ukraine

Search clinical trials for: Sistema Prevena ™(TVAC)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations